Delivery Order SPE2DB24D1205-SPE2DB25FCXZR

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,061.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide...
This is a $2,726.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used to treat seizures. This order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.92, is for the delivery of 4,566,087,298 units of the drug Nayzilam 5 mg nasal sprays. It is a firm fixed-price contract with an ultimate completion date of October 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This is a $1,182.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used for the acute treatment of seizure clusters. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. The contract has a ceiling value of $1,008.39 and runs through September 24, 2024. It is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous Indefinite Delivery Contracts...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.94, is for the supply of 4,567,875,332 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,069.86 firm fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4565906165 NAYZILAM 5 MG NASAL SPRAYS. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,174,376 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The total ceiling value of the contract is $10,634.56, with a period of performance through May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $1,336.03 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply NAYZILAM 5 MG NASAL SPRAYS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,548.30 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used for the treatment of seizures. The contract has an ultimate completion date of November 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCXZR
    Delivery Order

This is a $1,748.11 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nayzilam 5 mg nasal sprays, a medication used to treat seizures. The order has a completion date of June 25, 2025 and is not set aside for any special business category. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/28/25, 2:02 AM